Ineffectiveness of aprotinin on psoralen-UVA-(PUVA)-induced erythema.
Because bradykinin constitutes a possible candidate for mediation of topical 8-methoxypsoralen-UVA-(PUVA)-induced erythema, aprotinin (Trasylol), inhibitor of kallikrein and interrupter of the cascade leading to kinin production was assessed in guinea pigs. Response was assessed at 24, 48, and 72 hr after topical PUVA and there was no significant difference between normal saline and aprotinin by intradermal or intraperitoneal routes of administration. The results of this study indicate that intradermal and intraperiotoneal aprotinin, in the dose and method tested, is not capable of significantly decreasing erythema induced by topical PUVA in guinea pigs.
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D004890:Erythema / Q000517:prevention & control*; D011564:Furocoumarins / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006168:Guinea Pigs; D008297:Male; D010778:Photochemotherapy / Q000009:adverse effects*; D014467:Ultraviolet Therapy / Q000009:adverse effects
D011564:Furocoumarins; D007611:Aprotinin